Joanne E. Nash
Affiliations: | Cell and Systems Biology | University of Toronto, Toronto, ON, Canada |
Area:
Neuroscience BiologyGoogle:
"Joanne Nash"Mean distance: 53433
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Trinh D, Israwi AR, Brar H, et al. (2023) Parkinson's disease pathology is directly correlated to SIRT3 in human subjects and animal models: Implications for AAV.SIRT3-myc as a disease-modifying therapy. Neurobiology of Disease. 106287 |
| Trinh D, Israwi AR, Arathoon LR, et al. (2020) The multi-faceted role of mitochondria in the pathology of Parkinson's disease. Journal of Neurochemistry |
| Gleave JA, Arathoon LR, Trinh D, et al. (2018) Corrigendum to "Sirtuin 3 rescues neurons through the stabilisation of mitochondrial biogenetics in the virally-expressing mutant α-synuclein rat model of parkinsonism" [Neurobiol. Dis. 106 (2018) 133-146]. Neurobiology of Disease |
| Lu JYD, Su P, Barber JEM, et al. (2017) The neuroprotective effect of nicotine in Parkinson's disease models is associated with inhibiting PARP-1 and caspase-3 cleavage. Peerj. 5: e3933 |
| Arathoon LR, Gleave JA, Trinh D, et al. (2017) Sirtuin 3 rescues neurons through the stabilisation of mitochondrial biogenetics in the virally-expressing mutant α-synuclein rat model of parkinsonism. Neurobiology of Disease |
| Thiele SL, Chen B, Lo C, et al. (2014) Selective loss of bi-directional synaptic plasticity in the direct and indirect striatal output pathways accompanies generation of parkinsonism and l-DOPA induced dyskinesia in mouse models. Neurobiology of Disease. 71: 334-44 |
| Gleave JA, Perri PD, Nash JE. (2014) Mitochondrial dysfunction in Parkinson’s disease: a possible target for neuroprotection Frontiers in Biology. 9: 489-503 |
| Yong-Kee CJ, Warre R, Monnier PP, et al. (2012) Evidence for synergism between cell death mechanisms in a cellular model of neurodegeneration in parkinson's disease Neurotoxicity Research. 22: 355-364 |
| Thiele SL, Warre R, Nash JE. (2012) Development of a unilaterally-lesioned 6-OHDA mouse model of Parkinson's disease. Journal of Visualized Experiments : Jove |
| Johnston TH, Millar Z, Huot P, et al. (2012) A novel MDMA analogue, UWA-101, that lacks psychoactivity and cytotoxicity, enhances L-DOPA benefit in parkinsonian primates. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 26: 2154-63 |